JP2015509927A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015509927A5 JP2015509927A5 JP2014555678A JP2014555678A JP2015509927A5 JP 2015509927 A5 JP2015509927 A5 JP 2015509927A5 JP 2014555678 A JP2014555678 A JP 2014555678A JP 2014555678 A JP2014555678 A JP 2014555678A JP 2015509927 A5 JP2015509927 A5 JP 2015509927A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- unsubstituted
- cycloalkyl
- alkyl
- heterocycloalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims 25
- 150000001875 compounds Chemical class 0.000 claims 23
- 125000000217 alkyl group Chemical group 0.000 claims 20
- 125000001072 heteroaryl group Chemical group 0.000 claims 20
- 125000003118 aryl group Chemical group 0.000 claims 14
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 12
- 125000006716 (C1-C6) heteroalkyl group Chemical group 0.000 claims 8
- 125000000753 cycloalkyl group Chemical group 0.000 claims 8
- 125000003161 (C1-C6) alkylene group Chemical group 0.000 claims 7
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims 7
- 125000002993 cycloalkylene group Chemical group 0.000 claims 6
- 125000004404 heteroalkyl group Chemical group 0.000 claims 6
- 125000003107 substituted aryl group Chemical group 0.000 claims 6
- 125000000732 arylene group Chemical group 0.000 claims 5
- 229910052736 halogen Inorganic materials 0.000 claims 5
- 150000002367 halogens Chemical class 0.000 claims 5
- 125000005549 heteroarylene group Chemical group 0.000 claims 5
- 150000003839 salts Chemical class 0.000 claims 5
- 125000004474 heteroalkylene group Chemical group 0.000 claims 4
- 125000006588 heterocycloalkylene group Chemical group 0.000 claims 4
- 125000005346 substituted cycloalkyl group Chemical group 0.000 claims 4
- 125000003545 alkoxy group Chemical group 0.000 claims 3
- 229910052757 nitrogen Inorganic materials 0.000 claims 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 3
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 3
- 125000001424 substituent group Chemical group 0.000 claims 2
- 208000023275 Autoimmune disease Diseases 0.000 claims 1
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 239000012453 solvate Substances 0.000 claims 1
- 125000000547 substituted alkyl group Chemical group 0.000 claims 1
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261593146P | 2012-01-31 | 2012-01-31 | |
| US61/593,146 | 2012-01-31 | ||
| US201261637765P | 2012-04-24 | 2012-04-24 | |
| US61/637,765 | 2012-04-24 | ||
| US13/460,524 US8501724B1 (en) | 2012-01-31 | 2012-04-30 | Purinone compounds as kinase inhibitors |
| US13/460,524 | 2012-04-30 | ||
| PCT/US2013/023918 WO2013116382A1 (en) | 2012-01-31 | 2013-01-30 | Purinone compounds as kinase inhibitors |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017020756A Division JP6501209B2 (ja) | 2012-01-31 | 2017-02-07 | キナーゼ阻害剤としてのプリノン化合物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015509927A JP2015509927A (ja) | 2015-04-02 |
| JP2015509927A5 true JP2015509927A5 (enExample) | 2016-03-03 |
| JP6095075B2 JP6095075B2 (ja) | 2017-03-15 |
Family
ID=48870746
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014555678A Expired - Fee Related JP6095075B2 (ja) | 2012-01-31 | 2013-01-30 | キナーゼ阻害剤としてのプリノン化合物 |
| JP2017020756A Expired - Fee Related JP6501209B2 (ja) | 2012-01-31 | 2017-02-07 | キナーゼ阻害剤としてのプリノン化合物 |
| JP2018228582A Pending JP2019059758A (ja) | 2012-01-31 | 2018-12-05 | キナーゼ阻害剤としてのプリノン化合物 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017020756A Expired - Fee Related JP6501209B2 (ja) | 2012-01-31 | 2017-02-07 | キナーゼ阻害剤としてのプリノン化合物 |
| JP2018228582A Pending JP2019059758A (ja) | 2012-01-31 | 2018-12-05 | キナーゼ阻害剤としてのプリノン化合物 |
Country Status (14)
| Country | Link |
|---|---|
| US (3) | US8501724B1 (enExample) |
| EP (2) | EP3147285A3 (enExample) |
| JP (3) | JP6095075B2 (enExample) |
| KR (2) | KR20180030730A (enExample) |
| CN (2) | CN106279172A (enExample) |
| AU (3) | AU2013215166B2 (enExample) |
| BR (1) | BR112014018728A8 (enExample) |
| CA (2) | CA2940039A1 (enExample) |
| HK (1) | HK1203489A1 (enExample) |
| IL (1) | IL261282A (enExample) |
| MX (1) | MX2014009219A (enExample) |
| PH (1) | PH12014501815A1 (enExample) |
| RU (2) | RU2018118216A (enExample) |
| WO (1) | WO2013116382A1 (enExample) |
Families Citing this family (62)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA018573B1 (ru) | 2006-09-22 | 2013-09-30 | Фармасайкликс, Инк. | Ингибиторы тирозинкиназы брутона |
| US8809273B2 (en) | 2007-03-28 | 2014-08-19 | Pharmacyclics, Inc. | Inhibitors of Bruton's tyrosine kinase |
| CN105362277A (zh) | 2008-07-16 | 2016-03-02 | 药品循环有限公司 | 用于实体肿瘤的治疗的布鲁顿酪氨酸激酶的抑制剂 |
| CA3007787C (en) | 2010-06-03 | 2020-03-10 | Pharmacyclics Llc | The use of inhibitors of bruton's tyrosine kinase (btk) |
| US8962831B2 (en) | 2011-05-17 | 2015-02-24 | Principia Biopharma Inc. | Tyrosine kinase inhibitors |
| US9376438B2 (en) | 2011-05-17 | 2016-06-28 | Principia Biopharma, Inc. | Pyrazolopyrimidine derivatives as tyrosine kinase inhibitors |
| BR112014000653A2 (pt) | 2011-07-13 | 2017-02-14 | Pharmacyclics Inc | inibidores de tirosina quinase de bruton |
| PL3409278T3 (pl) | 2011-07-21 | 2021-02-22 | Sumitomo Pharma Oncology, Inc. | Heterocykliczne inhibitory kinazy białkowej |
| US8377946B1 (en) | 2011-12-30 | 2013-02-19 | Pharmacyclics, Inc. | Pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine compounds as kinase inhibitors |
| US8501724B1 (en) * | 2012-01-31 | 2013-08-06 | Pharmacyclics, Inc. | Purinone compounds as kinase inhibitors |
| EA201492082A1 (ru) | 2012-06-04 | 2015-03-31 | Фармасайкликс, Инк. | Кристаллические формы ингибитора тирозинкиназы брутона |
| CA2879570A1 (en) | 2012-07-24 | 2014-01-30 | Pharmacyclics, Inc. | Mutations associated with resistance to inhibitors of bruton's tyrosine kinase (btk) |
| AU2013312296B2 (en) | 2012-09-10 | 2017-06-22 | Principia Biopharma Inc. | Pyrazolopyrimidine compounds as kinase inhibitors |
| MX2015006168A (es) | 2012-11-15 | 2015-08-10 | Pharmacyclics Inc | Compuestos de pirrolopirimidina como inhibidores de quinasas. |
| US20140142099A1 (en) * | 2012-11-20 | 2014-05-22 | Principia Biopharma Inc. | Purinone Derivatives as Tyrosine Kinase Inhibitors |
| RU2693480C2 (ru) | 2013-03-14 | 2019-07-03 | Толеро Фармасьютикалз, Инк. | Ингибиторы jak2 и alk2 и способы их использования |
| CN105492011A (zh) | 2013-04-08 | 2016-04-13 | 丹尼斯·M·布朗 | 不理想给药化学化合物的治疗增效 |
| US8957080B2 (en) | 2013-04-09 | 2015-02-17 | Principia Biopharma Inc. | Tyrosine kinase inhibitors |
| JP6458018B2 (ja) * | 2013-07-02 | 2019-01-23 | ファーマサイクリックス エルエルシー | キナーゼ阻害剤としてのプリノン化合物 |
| TWI649081B (zh) | 2013-08-02 | 2019-02-01 | 製藥公司 | 治療固態腫瘤之方法 |
| ES2709509T3 (es) | 2013-08-12 | 2019-04-16 | Pharmacyclics Llc | Procedimientos para el tratamiento de cáncer amplificado por HER2 |
| KR20160062103A (ko) | 2013-09-30 | 2016-06-01 | 파마싸이클릭스 엘엘씨 | 브루톤 티로신 키나제의 억제제 |
| KR20160117614A (ko) | 2014-02-21 | 2016-10-10 | 프린시피아 바이오파마, 인코퍼레이티드 | Btk 억제제의 염 및 고체 형태 |
| EP3119910A4 (en) | 2014-03-20 | 2018-02-21 | Pharmacyclics LLC | Phospholipase c gamma 2 and resistance associated mutations |
| WO2015151006A1 (en) * | 2014-03-29 | 2015-10-08 | Lupin Limited | Substituted purine compounds as btk inhibitors |
| CN106999494A (zh) | 2014-08-01 | 2017-08-01 | 药品循环有限公司 | 布鲁顿酪氨酸激酶的抑制剂 |
| JP2017523206A (ja) | 2014-08-07 | 2017-08-17 | ファーマサイクリックス エルエルシー | ブルトン型チロシンキナーゼ阻害剤の新規製剤 |
| EA036269B1 (ru) | 2014-12-18 | 2020-10-21 | Принсипиа Биофарма Инк. | Лечение пузырчатки |
| IL315294A (en) | 2015-03-03 | 2024-10-01 | Pharmacyclics Llc | Pharmaceutical formulations of bruton's tyrosine kinase inhibitor |
| EP4112618A1 (en) | 2015-06-03 | 2023-01-04 | Principia Biopharma Inc. | Tyrosine kinase inhibitors |
| WO2016210165A1 (en) | 2015-06-24 | 2016-12-29 | Principia Biopharma Inc. | Tyrosine kinase inhibitors |
| CN105753863B (zh) * | 2015-09-11 | 2018-07-31 | 东莞市真兴贝特医药技术有限公司 | 氧代二氢咪唑并吡啶类化合物及其应用 |
| WO2017066014A1 (en) | 2015-10-14 | 2017-04-20 | Sunnylife Pharma Inc. | Bruton's tyrosine kinase inhibitors |
| RU2750151C2 (ru) | 2015-11-20 | 2021-06-22 | Форма Терапьютикс, Инк. | Гипоксантины в качестве ингибиторов убиквитин-специфической протеазы 1 |
| IL297192A (en) | 2016-04-15 | 2022-12-01 | Cancer Research Tech Ltd | Heterocyclic compounds as ret kinase inhibitors |
| SMT202200348T1 (it) | 2016-04-15 | 2022-11-18 | Cancer Research Tech Ltd | Composti eterociclici come inibitori della chinasi ret |
| EP3478273A1 (en) | 2016-06-29 | 2019-05-08 | Principia Biopharma Inc. | Modified release formulations of 2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-enenitrile |
| KR102459155B1 (ko) * | 2016-08-29 | 2022-10-28 | 에프. 호프만-라 로슈 아게 | 바이러스 감염의 치료 및 예방을 위한 7-치환된 설폰이미도일푸린온 화합물 |
| CN106588937B (zh) * | 2017-01-16 | 2018-09-21 | 东莞市真兴贝特医药技术有限公司 | 咪唑并吡嗪类化合物及其制备方法和应用 |
| JP2020508326A (ja) | 2017-02-24 | 2020-03-19 | ギリアド サイエンシズ， インコーポレイテッド | ブルトン型チロシンキナーゼの阻害剤 |
| AR110998A1 (es) | 2017-02-24 | 2019-05-22 | Gilead Sciences Inc | Inhibidores de la tirosina cinasa de bruton |
| GB201705971D0 (en) | 2017-04-13 | 2017-05-31 | Cancer Res Tech Ltd | Inhibitor compounds |
| CN109111446B (zh) | 2017-06-22 | 2021-11-30 | 上海度德医药科技有限公司 | 一种具有药物活性的杂芳基化合物 |
| EP3773591A4 (en) | 2018-04-05 | 2021-12-22 | Sumitomo Dainippon Pharma Oncology, Inc. | AXL KINASE INHIBITORS AND THEIR USE |
| CN117959303A (zh) | 2018-04-13 | 2024-05-03 | 住友制药肿瘤公司 | 用于治疗骨髓增殖性肿瘤和与癌症相关的纤维化的pim激酶抑制剂 |
| CA3103995A1 (en) | 2018-07-26 | 2020-01-30 | Sumitomo Dainippon Pharma Oncology, Inc. | Methods for treating diseases associated with abnormal acvr1 expression and acvr1 inhibitors for use in the same |
| CN110964016B (zh) | 2018-09-29 | 2021-05-28 | 南京药捷安康生物科技有限公司 | 氨基降茨烷衍生物及其制备方法与应用 |
| NZ778055A (en) | 2019-02-12 | 2025-11-28 | Sumitomo Pharma America Inc | Formulations comprising heterocyclic protein kinase inhibitors |
| BR112021018168B1 (pt) | 2019-03-21 | 2023-11-28 | Onxeo | Composição farmacêutica, combinação e kit compreendendo uma molécula dbait e um inibidor de quinase para o tratamento de câncer |
| EP4045051A1 (en) | 2019-10-14 | 2022-08-24 | Principia Biopharma Inc. | Methods for treating immune thrombocytopenia by administering (r)-2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-enenitrile |
| CA3159348A1 (en) | 2019-11-08 | 2021-05-14 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | Methods for the treatment of cancers that have acquired resistance to kinase inhibitors |
| CN115348862A (zh) | 2020-01-20 | 2022-11-15 | 建新公司 | 用于复发型多发性硬化症(rms)的治疗性酪氨酸激酶抑制剂 |
| WO2021148581A1 (en) | 2020-01-22 | 2021-07-29 | Onxeo | Novel dbait molecule and its use |
| PH12022551787A1 (en) | 2020-01-22 | 2024-02-12 | Principia Biopharma Inc | Crystalline forms of 2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)-1h-pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-enenitrile |
| KR102577689B1 (ko) | 2020-05-22 | 2023-09-12 | 코오롱인더스트리 주식회사 | 가스켓 조립체 및 이를 포함하는 연료전지 가습기 |
| CN113527300B (zh) * | 2020-06-04 | 2023-02-03 | 广州百霆医药科技有限公司 | 布鲁顿酪氨酸蛋白激酶抑制剂 |
| MX2023006854A (es) | 2020-12-10 | 2023-07-20 | Genzyme Corp | Forma cristalina de tolebrutinib, metodo de preparacion y uso de la misma. |
| CN117412749A (zh) * | 2021-05-21 | 2024-01-16 | 杭州领业医药科技有限公司 | Tolebrutinib盐及其晶型、其制备方法、其药物组合物和用途 |
| US20250154149A1 (en) * | 2022-02-16 | 2025-05-15 | Betta Pharmaceuticals Co., Ltd. | Pharmaceutical composition and method for preparing active ingredient compound thereof |
| EP4611753A1 (en) | 2022-10-31 | 2025-09-10 | Sumitomo Pharma America, Inc. | Pim1 inhibitor for treating myeloproliferative neoplasms |
| CN117777134B (zh) * | 2022-12-19 | 2025-02-25 | 艾立康药业股份有限公司 | 作为mat2a抑制剂的多环类化合物 |
| WO2025218778A1 (zh) * | 2024-04-19 | 2025-10-23 | 赛诺哈勃药业（成都）有限公司 | 杂环化合物及其作为ret抑制剂的用途 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5033252A (en) | 1987-12-23 | 1991-07-23 | Entravision, Inc. | Method of packaging and sterilizing a pharmaceutical product |
| US5052558A (en) | 1987-12-23 | 1991-10-01 | Entravision, Inc. | Packaged pharmaceutical product |
| US5323907A (en) | 1992-06-23 | 1994-06-28 | Multi-Comp, Inc. | Child resistant package assembly for dispensing pharmaceutical medications |
| US6326469B1 (en) | 1994-04-22 | 2001-12-04 | Sugen, Inc. | Megakaryocytic protein tyrosine kinases |
| US7071199B1 (en) * | 1999-09-17 | 2006-07-04 | Abbott Gmbh & Cco. Kg | Kinase inhibitors as therapeutic agents |
| ES2299434T3 (es) * | 1999-09-17 | 2008-06-01 | ABBOTT GMBH & CO. KG | Inhibidores de kinasa utilizados como agentes terapeuticos. |
| BR0316991A (pt) * | 2002-12-04 | 2005-10-25 | Eisai Co Ltd | Compostos de anel de 1,3-diidro-imidazol fundido |
| US20090023723A1 (en) * | 2005-09-21 | 2009-01-22 | Pharmacopeia Drug Discovery, Inc. | Purinone derivatives for treating neurodegenerative diseases |
| EA018573B1 (ru) * | 2006-09-22 | 2013-09-30 | Фармасайкликс, Инк. | Ингибиторы тирозинкиназы брутона |
| CA2669686A1 (en) * | 2006-11-16 | 2008-05-22 | Pharmacopeia, Llc | 7-substituted purine derivatives for immunosuppression |
| US20080119496A1 (en) | 2006-11-16 | 2008-05-22 | Pharmacopeia Drug Discovery, Inc. | 7-Substituted Purine Derivatives for Immunosuppression |
| SG10201508035TA (en) * | 2007-03-28 | 2015-10-29 | Pharmacyclics Inc | Inhibitors of bruton's tyrosine kinase |
| WO2011152351A1 (ja) * | 2010-05-31 | 2011-12-08 | 小野薬品工業株式会社 | プリノン誘導体 |
| US8501724B1 (en) * | 2012-01-31 | 2013-08-06 | Pharmacyclics, Inc. | Purinone compounds as kinase inhibitors |
| JP6458018B2 (ja) * | 2013-07-02 | 2019-01-23 | ファーマサイクリックス エルエルシー | キナーゼ阻害剤としてのプリノン化合物 |
-
2012
- 2012-04-30 US US13/460,524 patent/US8501724B1/en not_active Expired - Fee Related
-
2013
- 2013-01-30 MX MX2014009219A patent/MX2014009219A/es unknown
- 2013-01-30 EP EP16170469.7A patent/EP3147285A3/en not_active Withdrawn
- 2013-01-30 CA CA2940039A patent/CA2940039A1/en not_active Abandoned
- 2013-01-30 EP EP13743025.2A patent/EP2809672A4/en not_active Withdrawn
- 2013-01-30 RU RU2018118216A patent/RU2018118216A/ru not_active Application Discontinuation
- 2013-01-30 RU RU2014134141A patent/RU2655388C2/ru not_active IP Right Cessation
- 2013-01-30 BR BR112014018728A patent/BR112014018728A8/pt not_active Application Discontinuation
- 2013-01-30 WO PCT/US2013/023918 patent/WO2013116382A1/en not_active Ceased
- 2013-01-30 KR KR1020187007316A patent/KR20180030730A/ko not_active Ceased
- 2013-01-30 KR KR1020147024260A patent/KR101841325B1/ko not_active Expired - Fee Related
- 2013-01-30 CN CN201610685231.XA patent/CN106279172A/zh active Pending
- 2013-01-30 HK HK15103865.9A patent/HK1203489A1/xx unknown
- 2013-01-30 JP JP2014555678A patent/JP6095075B2/ja not_active Expired - Fee Related
- 2013-01-30 CN CN201380018581.5A patent/CN104640861B/zh not_active Expired - Fee Related
- 2013-01-30 AU AU2013215166A patent/AU2013215166B2/en not_active Ceased
- 2013-01-30 CA CA2863140A patent/CA2863140C/en not_active Expired - Fee Related
- 2013-01-30 US US14/375,765 patent/US9469642B2/en not_active Expired - Fee Related
-
2014
- 2014-07-31 PH PH12014501815A patent/PH12014501815A1/en unknown
-
2016
- 2016-07-01 US US15/200,834 patent/US20160368924A1/en not_active Abandoned
- 2016-07-20 AU AU2016206309A patent/AU2016206309A1/en not_active Abandoned
-
2017
- 2017-02-07 JP JP2017020756A patent/JP6501209B2/ja not_active Expired - Fee Related
-
2018
- 2018-02-20 AU AU2018201203A patent/AU2018201203A1/en not_active Abandoned
- 2018-08-21 IL IL261282A patent/IL261282A/en unknown
- 2018-12-05 JP JP2018228582A patent/JP2019059758A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015509927A5 (enExample) | ||
| JP2017114880A5 (enExample) | ||
| RU2018118216A (ru) | Соединения пуринона в качестве ингибиторов киназ | |
| JP2020530487A5 (enExample) | ||
| RU2477723C2 (ru) | Ингибиторы протеинкиназ (варианты), их применение для лечения онкологических заболеваний и фармацевтическая композиция на их основе | |
| JP2020169171A5 (enExample) | ||
| JP2016526558A5 (enExample) | ||
| JP2020531418A5 (enExample) | ||
| JP2020532545A5 (enExample) | ||
| JP2012500260A5 (enExample) | ||
| JP2012522003A5 (enExample) | ||
| RU2013152788A (ru) | Амидные соединения и их фармацевтическое применение | |
| JP2016510323A5 (enExample) | ||
| RU2016115934A (ru) | Конденсированное гетероциклическое соединение, способ его получения, его фармацевтическая композиция и применения | |
| JP2020529994A5 (enExample) | ||
| RU2019105534A (ru) | Модуляторы хемокинового рецептора и их применение | |
| JP2017504576A5 (enExample) | ||
| RU2015107803A (ru) | Производные дигидроксипиримидинкарбоновой кислоты и их применение в лечении, облегчении или предотвращении вирусного заболевания | |
| HRP20160253T1 (hr) | Inhibitor benzodiazepinske bromodomene | |
| JP2017512833A5 (enExample) | ||
| JP2007501859A5 (enExample) | ||
| RU2017117562A (ru) | Лекарственные средства на основе лантионинсинтетаза с-подобного белка | |
| JP2013525433A5 (enExample) | ||
| RU2010117156A (ru) | Гетероциклические соединения в качестве антагонистов crth2 рецептора | |
| AR077516A1 (es) | Composiciones farmaceuticas de uso oftalmico de antagonistas del receptor dp2. uso. compuesto. |